Filters
Hikma delivers strong first half results and raises full year guidance
Press Release, Corporate
Hikma appoints Dr Shahin Fesharaki as Chief Scientific Officer and Global Head of R&D
Press Release, Corporate
Hikma remains constituent of the FTSE4Good Index Series for 5th consecutive year
Press Release, Corporate
Hikma and Richter sign a license and supply agreement for cariprazine in MENA
Press Release, Corporate
Hikma and Civica Rx sign long-term agreement to reduce generic drug shortages in the US
Press Release, Corporate
Hikma Ventures participates in $11 million funding round for Pillo Health
Press Release, Corporate
Hikma announces positive start to 2019 and reiterates guidance
Press Release, Corporate
Hikma sponsors MIT Grand Hack to support global healthcare innovation
Press Release, Corporate
Hikma launches 100th injectable medicine in US with introduction of Vancomycin Hydrochloride for Injection, USP
Press Release, Product
Hikma participates in ‘World Economic Forum on the Middle East and North Africa’ at Dead Sea, Jordan
Press Release, Responsibility
Hikma launches Norepinephrine Bitartrate Injection, USP
Press Release, Product
Hikma delivers strong 2018 results and makes good strategic progress to position for future growth
Press Release, Corporate